Hjem › Diffust stort B-celle lymfom › Oklahoma › Oklahoma City
Diffust stort B-celle lymfom kliniske forsøg i Oklahoma City, OK
5 studier for Diffust stort B-celle lymfom søger deltagere på steder i og omkring Oklahoma City (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
RekruttererFase 1
- University of Oklahoma Health Sciences Center, Oklahoma City
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
RekruttererFase 1/2
- University of Oklahoma, Oklahoma City
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
RekruttererFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
RekruttererFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study of NX-1607 in Adults With Advanced Malignancies
RekruttererFase 1
- University of Oklahoma, Oklahoma City
Diffust stort B-celle lymfom forsøg i andre byer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Houston, TX17 studier
- Los Angeles, CA17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Nashville, TN15 studier
- Portland, OR15 studier
- Philadelphia, PA15 studier
- Durham, NC14 studier
- Dallas, TX13 studier
Andre studier i Oklahoma City
- Ikke-småcellet lungecancer28 studier
- Ægstockræft28 studier
- Livmoderslimhindekræft25 studier
- Colorektal kræft22 studier
- Prostatakræft21 studier
- Lungecancer19 studier
- Brystkræft17 studier
- Metastatisk cancer15 studier
- Kræft (alle typer)14 studier
- Akut myeloid leukæmi14 studier
- Pladecellekræft i hoved og hals13 studier
- Bugspytkirtelkræft11 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.